Literature DB >> 16611912

Differential chemokine expression following respiratory virus infection reflects Th1- or Th2-biased immunopathology.

Fiona J Culley1, Alasdair M J Pennycook, John S Tregoning, Tracy Hussell, Peter J M Openshaw.   

Abstract

Respiratory syncytial virus (RSV) is a major viral pathogen of infants that also reinfects adults. During RSV infection, inflammatory host cell recruitment to the lung plays a central role in determining disease outcome. Chemokines mediate cell recruitment to sites of inflammation and are influenced by, and influence, the production of cytokines. We therefore compared chemokine production in a mouse model of immunopathogenic RSV infection in which either Th1 or Th2 immunopathology is induced by prior sensitization to individual RSV proteins. Chemokine expression profiles were profoundly affected by the nature of the pulmonary immunopathology: "Th2" immunopathology in BALB/c mice was associated with increased and prolonged expression of CCL2 (MCP-1), CXCL10 (IP-10), and CCL11 (eotaxin) starting within 24 h of challenge. C57BL/6 mice with "Th2" pathology (enabled by a deficiency of CD8+ cells) also showed increased CCL2 production. No differences in chemokine receptor expression were detected. Chemokine blockers may therefore be of use for children with bronchiolitis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16611912      PMCID: PMC1472012          DOI: 10.1128/JVI.80.9.4521-4527.2006

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  37 in total

Review 1.  The biology of chemokines and their receptors.

Authors:  D Rossi; A Zlotnik
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

2.  IFN-gamma-inducible protein-10 is essential for the generation of a protective tumor-specific CD8 T cell response induced by single-chain IL-12 gene therapy.

Authors:  U Pertl; A D Luster; N M Varki; D Homann; G Gaedicke; R A Reisfeld; H N Lode
Journal:  J Immunol       Date:  2001-06-01       Impact factor: 5.422

3.  Chemokines in nasal secretions of normal adults experimentally infected with respiratory syncytial virus.

Authors:  T L Noah; S Becker
Journal:  Clin Immunol       Date:  2000-10       Impact factor: 3.969

4.  In BALB/c mice, IL-4 production during the initial phase of infection with Leishmania major is necessary and sufficient to instruct Th2 cell development resulting in progressive disease.

Authors:  H Himmelrich; P Launois; I Maillard; T Biedermann; F Tacchini-Cottier; R M Locksley; M Röcken; J A Louis
Journal:  J Immunol       Date:  2000-05-01       Impact factor: 5.422

5.  Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1.

Authors:  L Gu; S Tseng; R M Horner; C Tam; M Loda; B J Rollins
Journal:  Nature       Date:  2000-03-23       Impact factor: 49.962

6.  Inducible expression of inflammatory chemokines in respiratory syncytial virus-infected mice: role of MIP-1alpha in lung pathology.

Authors:  H A Haeberle; W A Kuziel; H J Dieterich; A Casola; Z Gatalica; R P Garofalo
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

7.  Respiratory syncytial virus G and/or SH glycoproteins modify CC and CXC chemokine mRNA expression in the BALB/c mouse.

Authors:  R A Tripp; L Jones; L J Anderson
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

8.  Murine eotaxin-2: a constitutive eosinophil chemokine induced by allergen challenge and IL-4 overexpression.

Authors:  N Zimmermann; S P Hogan; A Mishra; E B Brandt; T R Bodette; S M Pope; F D Finkelman; M E Rothenberg
Journal:  J Immunol       Date:  2000-11-15       Impact factor: 5.422

9.  Host genetic determinants of vaccine-induced eosinophilia during respiratory syncytial virus infection.

Authors:  T Hussell; A Georgiou; T E Sparer; S Matthews; P Pala; P J Openshaw
Journal:  J Immunol       Date:  1998-12-01       Impact factor: 5.422

10.  CC chemokine receptor (CCR)3/eotaxin is followed by CCR4/monocyte-derived chemokine in mediating pulmonary T helper lymphocyte type 2 recruitment after serial antigen challenge in vivo.

Authors:  C M Lloyd; T Delaney; T Nguyen; J Tian; C Martinez-A; A J Coyle; J C Gutierrez-Ramos
Journal:  J Exp Med       Date:  2000-01-17       Impact factor: 14.307

View more
  47 in total

1.  Comparative analysis of immune responses to Russian spring-summer encephalitis and Omsk hemorrhagic fever viruses in mouse models.

Authors:  Bersabeh Tigabu; Terry Juelich; Michael R Holbrook
Journal:  Virology       Date:  2010-09-28       Impact factor: 3.616

Review 2.  The virome in host health and disease.

Authors:  Ken Cadwell
Journal:  Immunity       Date:  2015-05-19       Impact factor: 31.745

3.  Respiratory virus-induced regulation of asthma-like responses in mice depends upon CD8 T cells and interferon-gamma production.

Authors:  Joost J Smit; Louis Boon; Nicholas W Lukacs
Journal:  Am J Pathol       Date:  2007-11-08       Impact factor: 4.307

4.  Protective T cell immunity against respiratory syncytial virus is efficiently induced by recombinant BCG.

Authors:  Susan M Bueno; Pablo A González; Kelly M Cautivo; Jorge E Mora; Eduardo D Leiva; Hugo E Tobar; Glenn J Fennelly; Eliseo A Eugenin; William R Jacobs; Claudia A Riedel; Alexis M Kalergis
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-15       Impact factor: 11.205

5.  Serum IP-10 as a biomarker of human rhinovirus infection at exacerbation of COPD.

Authors:  Jennifer K Quint; Gavin C Donaldson; James J P Goldring; Ramin Baghai-Ravary; John R Hurst; Jadwiga A Wedzicha
Journal:  Chest       Date:  2009-10-16       Impact factor: 9.410

6.  Overcoming T cell-mediated immunopathology to achieve safe RSV vaccination.

Authors:  Elaine M Castilow; Steven M Varga
Journal:  Future Virol       Date:  2008       Impact factor: 1.831

7.  The chemokine MIP1alpha/CCL3 determines pathology in primary RSV infection by regulating the balance of T cell populations in the murine lung.

Authors:  John S Tregoning; Philippa K Pribul; Alasdair M J Pennycook; Tracy Hussell; Belinda Wang; Nicholas Lukacs; Jurgen Schwarze; Fiona J Culley; Peter J M Openshaw
Journal:  PLoS One       Date:  2010-02-24       Impact factor: 3.240

Review 8.  Early life microbial exposures and allergy risks: opportunities for prevention.

Authors:  Harald Renz; Chrysanthi Skevaki
Journal:  Nat Rev Immunol       Date:  2020-09-11       Impact factor: 53.106

9.  Sequential exposure to carbon nanotubes and bacteria enhances pulmonary inflammation and infectivity.

Authors:  Anna A Shvedova; James P Fabisiak; Elena R Kisin; Ashley R Murray; Jenny R Roberts; Yulia Y Tyurina; James M Antonini; Wei Hong Feng; Choudari Kommineni; Jeffrey Reynolds; Aaron Barchowsky; Vince Castranova; Valerian E Kagan
Journal:  Am J Respir Cell Mol Biol       Date:  2007-12-20       Impact factor: 6.914

10.  Virally delivered cytokines alter the immune response to future lung infections.

Authors:  James Harker; Alexander Bukreyev; Peter L Collins; Belinda Wang; Peter J M Openshaw; John S Tregoning
Journal:  J Virol       Date:  2007-09-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.